About PriceSpective LLC

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
pharmaceuticals
Location
Location
United States
Description
Information
The Expertise to Achieve Maximum Product Potential ICON’s Commercialisation & Outcomes practices provide insights to clients on strategies and execution for long-term value through customised engagements that fit the compound, the company and the market, maximising products' success and their benefits to patients’ health. The combined strengths in our scientific practices and operational delivery teams offer tremendous opportunity to harness expertise and capabilities from multiple disciplines at once, or in sequence, creating a stronger and more persistent focus on product value and commercial success. Specialty practices directed toward product commercialisation include: Peri-approval & Observational Research Pricing & Market Access Health Economics Patient Reported Outcomes Epidemiology Electronic Clinical Outcomes Assessment Language Services ICON Commercialisation & Outcomes ultimately helps clients make the best decisions based on academically rigorous and commercially relevant expertise and services early in development so that they can introduce the highest value product into the market place in the shortest time.

PriceSpective LLC Alternatives

Frequently Asked Questions about PriceSpective LLC

What is PriceSpective LLC email format?

The widely used PriceSpective LLC email format is {f}{last} (e.g. [email protected]) with 100% adoption across the company.


What is PriceSpective LLC customer service number?

To contact PriceSpective LLC customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more